Skip to content
10-K

Annual Report

SPRING PHARMACEUTICAL GROUP, INC.

0001096906-17-000447

← back to feed
Filed
Jun 29, 2017 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Jun 28, 2017 29.79M sh
Operating Cash Flow FY 2016 · Mar 31, 2017 $9.74M
Operating Cash Flow FY 2016 · Mar 31, 2016 $8.55M
Capex FY 2016 · Mar 31, 2016 $1.53M
Stockholders Equity FY 2016 · Mar 31, 2016 $80.35M
Stockholders Equity FY 2016 · Mar 31, 2015 $75.41M
Current Liabilities restated FY 2016 · Mar 31, 2016 $929.32K
Current Assets FY 2016 · Mar 31, 2016 $11.42M
Total Assets restated FY 2016 · Mar 31, 2016 $81.28M
Sga Expense FY 2016 · Mar 31, 2016 $4.45M
Rd Expense FY 2016 · Mar 31, 2016 $724.29K
Net Income FY 2016 · Mar 31, 2016 $8.42M
Operating Income FY 2016 · Mar 31, 2016 $11.23M
Gross Profit FY 2016 · Mar 31, 2016 $21.27M
Revenue FY 2016 · Mar 31, 2016 $47.83M
Cash And Equivalents FY 2016 · Mar 31, 2015 $13.08M